Moderna reports higher immune response for next-generation COVID vaccine

Moderna reports promising findings for next-generation COVID vaccine The new version offers longer shelf-life advantages and paves the way for a flu-COVID combo vaccine. CIDRAP

...

The mRNA-1283 vaccine showed a higher immune response—including in seniors—than its currently licensed vaccine, called mRNA-1273.222. Response was higher against Omicron BA.4/BA.5 as well as the original SARS-CoV-2 virus.

...